Echo Street Capital Management LLC Intellia Therapeutics, Inc. Transaction History

Echo Street Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$34.58 - $46.03 $191,780 - $255,282	5,546 New	5,546 $226,000
Q4 2022 Feb 13, 2023	BUY	$33.21 - $62.69 $523,024 - $987,304	15,749 Added 237.08%	22,392 $781,000
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $358,190 - $476,303	6,643 New	6,643 $372,000
Q2 2022 Aug 15, 2022	SELL	$38.49 - $76.21 $466,383 - $923,436	-12,117 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $706,057 - $1.44 Million	12,117 New	12,117 $881,000
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $232,856 - $319,749	-2,311 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $305,907 - $408,538	2,311 New	2,311 $310,000

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $867M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.